Abstract

Differences between the 2010 and 2018 guidelines:

  • Reflects newer published data and prospects of advances in diagnosis and treatments
  • Emphasizes shared decision making among congenital adrenal hyperplasia patients, their families, and healthcare professionals when it comes to the medical, surgical, and psychological management of the disorder
  • Includes more detailed protocols for adults, especially pregnant women
  • Discusses potential new therapies and future ways to improve quality of life for individuals with congenital adrenal hyperplasia